Journal of Southern Medical University ›› 2024, Vol. 44 ›› Issue (9): 1760-1768.doi: 10.12122/j.issn.1673-4254.2024.09.16
Previous Articles Next Articles
Hui ZHANG1(), Yangyang LIU2(
), Xiapeng LI3, Mengyao WANG2, Li LI2,3(
), Haitao WEI3(
)
Received:
2024-07-04
Online:
2024-09-20
Published:
2024-09-30
Contact:
Li LI, Haitao WEI
E-mail:3835206455@qq.com;104754222009@henu.edu.cn;10210051@vip.henu.edu.cn;taoge9885@163.com
Hui ZHANG, Yangyang LIU, Xiapeng LI, Mengyao WANG, Li LI, Haitao WEI. High KHSRP expression promotes gastric adenocarcinoma metastasis: the mediating role of the JAK1/STAT3 signaling axis[J]. Journal of Southern Medical University, 2024, 44(9): 1760-1768.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.j-smu.com/EN/10.12122/j.issn.1673-4254.2024.09.16
Primer | Sequence (5'-3') |
---|---|
KHSRP mRNA-R | AATGAGTACGGATCTCGGATTGG |
KHSRP mRNA-F | CCGTCATCTTGCTTGAACTGTA |
GAPDH-R | 5'-GAAGGTGAAGGTCGGAGTC-3 |
GAPDH-F | 5'-GAAGATGGTGATGGGATTTC-3' |
U6-R | 5'-CGCTTCGGCACATATACTA-3' |
U6-F | 5'-CGCTTCACGAATTTGCGTGTCA-3' |
Tab.1 Sequences of the primers for RT-qPCR
Primer | Sequence (5'-3') |
---|---|
KHSRP mRNA-R | AATGAGTACGGATCTCGGATTGG |
KHSRP mRNA-F | CCGTCATCTTGCTTGAACTGTA |
GAPDH-R | 5'-GAAGGTGAAGGTCGGAGTC-3 |
GAPDH-F | 5'-GAAGATGGTGATGGGATTTC-3' |
U6-R | 5'-CGCTTCGGCACATATACTA-3' |
U6-F | 5'-CGCTTCACGAATTTGCGTGTCA-3' |
Fig.1 KHSRP is highly expressed in gastric adenocarcinoma. A: Immunohistochemical staining of gastric adenocarcinoma and adjacent tissues. B: Western blotting for detecting KHSRP in gastric adenocarcinoma and adjacent tissues. C: KHSRP protein expression level in gastric adenocarcinoma and adjacent tissues. D: Correlation of expression levels of KHSRP with overall survival rate of the patients.
Fig.2 High KHSRP expression promotes proliferation, migration, and invasion of gastric adenocarcinoma cells. A: Transfection efficiency in MNK-28, HGC-27, CRL-5822, and SNU-1 cells assessed by RT-qPCR. B: Proliferation of the transfected cells assessed using CCK-8 assay. C: Transwell assay for assessing migration and invasion of the transfected cells. D: Statistical analysis of the results of Transwell assay. *P<0.05, **P<0.01.
Fig.3 High KHSRP expression promote growth, migration and invasion of gastric adenocarcinoma cells in nude mice. A-D: Dissected subcutaneous tumors from nude mice and quantitative analysis of tumor weight and volume. E, F: Dissected lung metastatic tumors of gastric adenocarcinoma and HE staining (Original magnification: ×200). G: Quantitative analysis of lung metastatic nodules of derived from different gastric adenocarcinoma cells after tail vein injection. *P<0.05, **P<0.01.
Fig.4 RT-qPCR for detecting mRNA expressions of JAK/STAT pathway-related proteins in HGC-27 cells with KHSRP knockdown (A) and SNU-1 cells with KHSRP overexpression (B). **P<0.01.
Fig.5 Western blotting for detecting expressions of JAK/STAT pathway-related proteins in HGC-27 cells with KHSRP knockdown and SNU-1 cells with KHSRP overexpression. A: Western blots of the proteins. B: Quantitative analysis of the protein expression levels. **P<0.01.
Fig.6 High expression of KHSRP promotes proliferation, migration and invasion of gastric adenocarcinoma cells by regulating JAK1, STAT3 signaling pathway. A, B: RT-qPCR for assessing transfection efficiency of HGC-27sh-JAK1 and HGC-27sh-STAT3 cells. C: CCK-8 assay of HGC-27 cells showed that KHSRP overexpression attenuated inhibitory effects of sh-JAK1 and sh-STAT3 on cell proliferation. D: Transwell assay showing that KHSRP overexpression promoted migration and invasion of HGC-27sh-JAK1 and HGC-27sh-STAT3 cells. *P<0.05 vs HGC-27sh-NC, **P<0.01 vs HGC-27sh-NC.
1 | Joseph A, Raja S, Kamath S, et al. Esophageal adenocarcinoma: a dire need for early detection and treatment[J]. Cleve Clin J Med, 2022, 89(5): 269-79. |
2 | Chang JJ, Wu H, Wu J, et al. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune micro-environment and predicting survival in stomach adenocarcinoma[J]. J Transl Med, 2023, 21(1): 191. |
3 | Gallo A, Ronzio M, Bezzecchi E, et al. NF-Y subunits overexpression in gastric adenocarcinomas (STAD)[J]. Sci Rep, 2021, 11(1): 23764. |
4 | Zhang M, Hu SF, Min M, et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing[J]. Gut, 2021, 70(3): 464-75. |
5 | Yang M, Sun XB, Chen YY, et al. Twenty cases of gastric adenocarcinoma of the fundic gland type[J]. Scand J Gastroenterol, 2023, 58(7): 744-50. |
6 | Stancu MI, Giubelan A, Mitroi G, et al. Assessment of tumor microenvironment in gastric adenocarcinoma[J]. Rom J Morphol Embryol, 2023, 64(2): 251-61. |
7 | Xu JY, Wang DS, Ma HL, et al. KHSRP combines transcriptional and posttranscriptional mechanisms to regulate monocytic differentiation[J]. Blood Sci, 2022, 4(3): 103-15. |
8 | Olguin SL, Patel P, Buchanan CN, et al. KHSRP loss increases neuronal growth and synaptic transmission and alters memory consolidation through RNA stabilization[J]. Commun Biol, 2022, 5(1): 672. |
9 | Zhao Y, Wen SM, Li H, et al. Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification[J]. Theranostics, 2023, 13(2): 596-610. |
10 | Paizula X, Wulaying A, Chen D, et al. KHSRP has oncogenic functions and regulates the expression and alternative splicing of DNA repair genes in breast cancer MDA-MB-231 cells[J]. Sci Rep, 2024, 14(1): 14694. |
11 | Sidali A, Teotia V, Solaiman NS, et al. AU-rich element RNA binding proteins: At the crossroads of post-transcriptional regulation and genome integrity[J]. Int J Mol Sci, 2021, 23(1): 96. |
12 | Yang YC, Lin YW, Lee WJ, et al. The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase[J]. J Biomed Sci, 2023, 30(1): 68. |
13 | Liu Z, Wang XY, Liu L, et al. Long non-coding RNA SLC7A11 antisense RNA1 promotes oral squamous cell carcinoma progression by regulating ubiquitination of K-homology type splicing regulatory protein[J]. Arch Oral Biol, 2023, 154: 105762. |
14 | Chen MM, Wang SL. Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy[J]. Int Immunopharmacol, 2024, 130: 111717. |
15 | Hu Q, Bian QH, Rong DC, et al. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens[J]. Front Bioeng Biotechnol, 2023, 11: 1110765. |
16 | Xue C, Yao QF, Gu XY, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer[J]. Signal Transduct Target Ther, 2023, 8(1): 204. |
17 | Qin Z, Yue MT, Tang SJ, et al. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation[J]. J Exp Med, 2024, 221(3): e20232028. |
18 | Hjazi A, Obaid RF, Ali SS, et al. The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer[J]. Pathol Res Pract, 2023, 248: 154657. |
19 | Hu XY, Li J, Fu MR, et al. The JAK/STAT signaling pathway: from bench to clinic[J]. Signal Transduct Target Ther, 2021, 6(1): 402. |
20 | López-Mejía JA, Mantilla-Ollarves JC, Rocha-Zavaleta L. Modulation of JAK-STAT signaling by LNK: a forgotten oncogenic pathway in hormone receptor-positive breast cancer[J]. Int J Mol Sci, 2023, 24(19): 14777. |
21 | Gravina AG, Pellegrino R, Esposito A, et al. The JAK-STAT pathway as a therapeutic strategy in cancer patients with immune checkpoint inhibitor-induced colitis: a narrative review[J]. Cancers, 2024, 16(3): 611. |
22 | Wang YH, Wang Z, Li SY, et al. Deciphering JAK/STAT signaling pathway: a multifaceted approach to tumorigenesis, progression and therapeutic interventions[J]. Int Immunopharmacol, 2024, 131: 111846. |
23 | Guo H, Zhang C, Tang XT, et al. HHLA2 activates the JAK/STAT signaling pathway by binding to TMIGD2 in hepatocellular carcinoma cells[J]. Inflammation, 2022, 45(4): 1585-99. |
24 | Wang L, Zhao DF, Wang H, et al. FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway[J]. Int Immunopharmacol, 2021, 100: 108117. |
25 | Wang S, Xia D, Wang XZ, et al. C/EBPβ regulates the JAK/STAT signaling pathway in triple-negative breast cancer[J]. FEBS Open Bio, 2021, 11(4): 1250-8. |
26 | Sun YC, Gong WP, Zhang S. METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway[J]. Cell Death Dis, 2023, 14(11): 765. |
27 | Cheng C, Cai YX, Liu XW, et al. KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor[J]. Cell Signal, 2022, 100: 110447. |
28 | Yuan HH, Cai RJ, Chen BY, et al. Acetylated KHSRP impairs DNA-damage-response-related mRNA decay and facilitates prostate cancer tumorigenesis[J]. Mol Oncol, 2024 :doi: 10.1002/1878-0261.13634. Online ahead of print. |
29 | Long F, Li L, Xie CB, et al. Intergenic CircRNA Circ_0007379 inhibits colorectal cancer progression by modulating miR-320a biogenesis in a KSRP-dependent manner[J]. Int J Biol Sci, 2023, 19(12): 3781-803. |
30 | Taniuchi K, Ogasawara M. Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer[J]. Oncotarget, 2023, 14: 104. |
31 | Liu LF, Han L, Ma QZ, et al. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: a case report[J]. Medicine, 2021, 100(21): e25861. |
32 | Park H, Lee S, Lee J, et al. Exploring the JAK/STAT signaling pathway in hepatocellular carcinoma: unraveling signaling complexity and therapeutic implications[J]. Int J Mol Sci, 2023, 24(18): 13764. |
33 | Zhang CN, Gu LQ, Xiao J, et al. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer[J]. BMC Cancer, 2023, 23(1): 684. |
34 | Zhu JF, Li Y, Lv X. IL4I1 enhances PD-L1 expression through JAK/STAT signaling pathway in lung adenocarcinoma[J]. Immuno-genetics, 2023, 75(1): 17-25. |
35 | Rusek M, Smith J, El-Khatib K, et al. The role of the JAK/STAT signaling pathway in the pathogenesis of Alzheimer's disease: new potential treatment target[J]. Int J Mol Sci, 2023, 24(1): 864. |
36 | Gao AH, Hu YR, Zhu WP. IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway[J]. Clin Transl Oncol, 2022, 24(1): 57-65. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||